ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

 News | News By Subject | News By Date | Search News

Clinical News Articles on Industry Topics

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
 Featured Stories
Long Term, Regular Aspirin Use May Reduce Cancer Risk, Harvard School of Public Health Study     4/20/2015
Remote Tribepeople Carry Antibiotic Resistance Genes, Washington University in St. Louis Study     4/20/2015
Broccoli Sprout May Prevent Head and Neck Cancer, University of Pittsburgh Cancer Institute (UPCI) Study     4/20/2015
Soyfoods Reduce Breast Cancer Recurrence, Georgetown University Medical Center Study     4/20/2015
MRIs Show Rebellious Teens React To Parents, University of Southern California Study     4/20/2015
Kids With ADHD Must Squirm To Learn, University of Central Florida Study Says     4/20/2015
Brain Scans Give Clues to Link Between Alzheimer's, Down Syndrome, Alzheimer's & Dementia Reveals     4/20/2015
The Number One Cause Of Depression - Everywhere     4/17/2015
 More News
Ampio Pharmaceuticals, Inc. (AMPE) Shares Decimated on Failed Trial Results     4/20/2015
KEYTRUDA (Pembrolizumab), Merck & Co. (MRK)’s Anti-PD-1 Therapy, Demonstrates Superior Survival, Progression Free Survival And Overall Response Rate Compared To Ipilimumab An Anti-CTLA-4 Therapy     4/20/2015
Full Data On Baxter International (BAX)’s Investigational Recombinant Treatment BAX 111 Supports Potential Role To Treat Von Willebrand Disease     4/20/2015
Cyclacel Pharmaceuticals, Inc. (CYCC)'s Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential And Synergy With Other Anti-Cancer Compounds     4/20/2015
Onconova Therapeutics Inc. (ONTX) Submits Pivotal Clinical Trial Protocol For IV Rigosertib In Higher-Risk Myelodysplastic Syndromes To FDA And European Medicines Agency     4/20/2015
Data Presented At AACR Demonstrate Peregrine Pharmaceuticals, Inc. (PPHM)' Bavituximab Induces Immune Activation In PD-L1 Negative NSCLC Tumors     4/20/2015
Pembrolizumab, Merck & Co. (MRK)'s Investigational Anti PD-1 Therapy, Demonstrates Superior Survival, Progression Free Survival And Overall Response Rate Compared To Ipilimumab, An Anti-CTLA-4 Therapy, In A Phase 3 Study Of Patients With Advanced Melanoma     4/20/2015
Merz Neurosciences To Present Key Clinical Data At The Annual Meeting Of The American Academy of Neurology     4/20/2015
Bio Products Laboratory, Ltd. Announces Results From Phase III Registration Study Of Its Factor X Coagulation Product     4/20/2015
Anika Therapeutics (ANIK)' Cingal 13-02 Study Meets Primary Endpoint     4/20/2015
Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals, Inc.'s NP001 Potential Efficacy And Safety In ALS     4/20/2015
Nymox Pharmaceutical (NYMX) Announces New Prostate Cancer Clinical Trial Results     4/20/2015
Merck & Co. (MRK) Release: Treatment Of Advanced Non-Small Cell Lung Cancer (NSCLC) With Pembrolizumab Presented At AACR Annual Meeting And Published In The New England Journal of Medicine     4/20/2015
Immunocore Limited Announces Positive Clinical Trial Data For Novel First-in-Class Immunotherapy At AACR Annual Meeting 2015     4/20/2015
Halozyme Therapeutics, Inc. (HALO) Presents New Preclinical Data At AACR Annual Meeting, Announces Clinical Data Presentation At ASCO     4/20/2015
Kamada Ltd. (KMDA) Reports Additional Data From European Phase 2/3 Clinical Study Of Inhaled Alpha-1 Antitrypsin To Treat AAT Deficiency     4/20/2015
Pharmacyclics (PCYC) Release: IMBRUVICA (ibrutinib) Longer-Term Follow-Up Data Demonstrate Durable Responses, Including Complete Responses, In Patients With Chronic Lymphocytic Leukemia (CLL)     4/20/2015
Bristol-Myers Squibb (BMY) Release: First Randomized Study Evaluating Opdivo (Nivolumab)+Yervoy (Ipilimumab) Regimen Demonstrates Superior Efficacy Versus Yervoy Alone In Patients With Previously Untreated Advanced Melanoma     4/20/2015
Patients With Advanced Breast, Lung, Esophageal, And Colorectal Cancers Respond To Immunomedics, Inc. (IMMU)' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments     4/20/2015
Early Findings With KEYTRUDA (Pembrolizumab), Merck & Co. (MRK)’s Anti-PD-1 Therapy, In Patients With Advanced Pleural Mesothelioma Presented At American Association for Cancer Research Annual Meeting     4/20/2015
Eli Lilly (LLY)'s Ixekizumab Met Primary Endpoint In A Phase 3 Study Investigating The Treatment Of Psoriatic Arthritis     4/20/2015
ChemoCentryx, Inc. (CCXI) Initiates Clinical Trial Of CCX872, Its Next-Generation, Orally Administered CCR2 Inhibitor, In Pancreatic Cancer     4/20/2015
OncoCyte Corporation Announces Initial Data From Ongoing Clinical Study Of Collagen Type X As A Marker And Potential Diagnostic For Breast Cancer And Other Types Of Human Cancers     4/20/2015
PTC Therapeutics (PTCT) Phase 1 Data From Spinal Muscular Atrophy Program To Be Presented At The 2015 American Academy of Neurology Annual Meeting     4/20/2015
Actavis (ACT) Announces FDA Approval Of Expanded Label For Botox (Onabotulinumtoxina) For The Treatment Of Upper Limb Spasticity In Adults     4/20/2015
The Medicines Company (MDCO) Release: FDA Approves New Formulation Of MINOCIN (Minocycline) For Injection     4/20/2015
Oasmia's Lead Cancer Product Paclical® Receives Market Approval In The Russian Federation     4/20/2015
Seattle Genetics, Inc. (SGEN) Release: FDA Accepts Supplemental BLA And Grants Priority Review For ADCETRIS (Brentuximab Vedotin) In The AETHERA Setting For The Post-Transplant Consolidation Treatment Of Hodgkin Lymphoma Patients At High Risk Of Relapse     4/20/2015
MediWound (MDWD) Initiates U.S. Phase 3 Trial With NexoBrid To Treat Severe Burns     4/20/2015
SAGE Therapeutics Announces First Patient Treated Under Phase 3 Expanded Access Protocol To Evaluate SAGE-547 In Patients With Super-Refractory Status Epilepticus     4/20/2015
Global Strategic Partners Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Pfizer (PFE) nitiate Phase III Study With Avelumab* In Patients With Stage IIIb/IV Non-Small Cell Lung Cancer     4/20/2015
Pluristem Therapeutics (PSTI)'s Clinical Advisory Board Prepares Phase II Clinical Trials In Critical Limb Ischemia In Europe And Japan     4/20/2015
Otonomy, Inc. (OTIC) Completes Enrollment Of OTO-104 Multiple-Dose Safety Study In Meniere's Disease Patients     4/20/2015
Bionomics Limited (BNO.AX) Initiates Phase II Clinical Trial Of BNC210 For Treatment Of Anxiety     4/20/2015
DelMar Pharmaceuticals Presents Updated Clinical Data On Phase I/II Study Of VAL-083 In Refractory Glioblastoma Multiforme (GBM)     4/20/2015
Can-Fite BioPharma (CFBI) Applies For Orphan Drug Designation In Europe For CF102 In The Treatment Of Liver Cancer     4/20/2015
FDA Grants Fast Track Designation To Eiger Biopharma's Lonafarnib For Hepatitis Delta Virus (HDV) Infection     4/20/2015
cCam Biotherapeutics Announces Initiation Of Phase 1 Trial Of CM-24, A Novel Immune Checkpoint Inhibitor For Cancer Immunotherapy     4/20/2015
Cardio3 Biosciences Announces Infusion Of First Patient In NKG2D Phase I Trial With No Short Term Adverse Events     4/20/2015
Momenta Pharmaceuticals, Inc. (MNTA) Presents Key Glatopa (Glatiramer Acetate Injection) Data At American Academy of Neurology Annual Meeting     4/20/2015
Biogen (BIIB) Release: TECFIDERA (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy For Newly-Diagnosed MS Patients     4/20/2015
Tokai Pharmaceuticals (TKAI) Announces Preclinical Results From The University of Maryland Showing Galeterone And Analogs Inhibit Pancreatic Cancer Cell Growth     4/20/2015
Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity Of BLU-285 In Treatment-Resistant GIST And On Novel Cancer Drug Targets     4/20/2015
Rexahn Pharmaceuticals, Inc. (RNN) Identifies RX-3117 Biomarker & Presents Data At The 2015 AACR Annual Meeting     4/20/2015
Celldex (CLDX)'s Varlilumab Demonstrates Synergistic Anti-Tumor Activity With PD-1 Signaling Blockade In Preclinical Studies     4/20/2015
DelMar Pharmaceuticals Presents Positive Preclinical Data On Val-083 For Treatment Of Non-Small Cell Lung Cancer At AACR Annual Meeting     4/20/2015
TG Therapeutics, Inc. (MHA) Presents Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting     4/20/2015
Imugene Limited (IMU.AX) Release: HER-Vaxx Re-Formulation Shows Dramatic Ten-Fold Increase In Antibodies And Early Onset Of Response; Additional Milestone Met     4/20/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Data At The 2015 AACR Annual Meeting     4/20/2015
NanoViricides, Inc. (NNVC.PK) Reports That Its Topical Anti-Herpes Treatment Dramatically Improves Clinical Symptoms In An Animal Model     4/20/2015
AVEO Oncology (AVEO) Announces Presentation Of AV-380 Preclinical Data In Cancer Associated Cachexia At 2015 Annual Meeting Of The AACR     4/20/2015
Pharmacyclics (PCYC) Release: Ibrutinib (IMBRUVICA) Improves OutcomesFor Pancreatic Ductal Adenocarcinoma In Mouse Models     4/20/2015
Acetylon Pharmaceuticals Announces Preclinical Anti-Cancer Activity Of Selective HDAC1/2 Inhibitors In Neuroblastoma And Acute Myeloid Leukemia     4/20/2015
DelMar Pharmaceuticals Presents Promising Preclinical Data On VAL-083's Potential To Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM)     4/20/2015
Peloton Therapeutics Presents Promising Data On First Inhibitor Of HIF-2a For Renal Cell Carcinoma At 2015 AACR Annual Meeting     4/20/2015
Ligand Pharmaceuticals Inc. (LGND) Partner TG Therapeutics, Inc. (MHA) Presents Positive Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting     4/20/2015
Epizyme (EPZM) Presents Preclinical Research Providing Deeper Understanding Of Multiple Cancer Targets     4/20/2015
Results From The Sidney Kimmel Cancer Center At Thomas Jefferson University     4/20/2015
Case Western Reserve University Release: Drugs Stimulate Body’s Own Stem Cells To Replace The Brain Cells Lost In Multiple Sclerosis     4/20/2015
Portage Biotech's CPP Platform Delivers A Peptide Cargo Across Blood Brain Barrier     4/20/2015
Immuron (ASX:IMC) Announces First USA Orders For Travelan     4/20/2015
Huntingdon Life Sciences And Harlan Laboratories, Inc. Announce The Launch Of The Shrntm Novel Hairless NOD.SCID Model At AACR 2015     4/20/2015
BioPharmX Announces Violet Iodine is Now Available At The Vitamin Shoppe     4/20/2015
Lupin Ltd. (LUPN.BO) Launches Zaxine In Canada     4/20/2015
Epizyme (EPZM) To Present Updated Data From Ongoing Phase 1 Dose Escalation Trial Of EZH2 Inhibitor EPZ-6438 At International Conference On Malignant Lymphoma     4/20/2015
Atara Biotherapeutics (ATRA)' Collaborating Investigators' Abstract On T-Cell Therapy For EBV Lymphoma To Be Presented At A Clinical Trials Plenary Session At The American Association for Cancer Research Annual Meeting 2015 Is Now Available     4/20/2015
EBV-CTL Clinical Trial Data Presented By Atara Biotherapeutics' Collaborating Investigators At A Plenary Session At The AACR Annual Meeting 2015     4/20/2015
Genticel To Present Further Promising Pharmacology In-Vivo Results Of Its Phase 2 Immunotherapeutic Vaccine Candidate, GTL001 (Procervix), At AACR Annual Meeting 2015     4/20/2015
Argos Therapeutics, Inc. (ARGS) To Present Update On Pivotal Phase 3 ADAPT Clinical Trial During 2015 ASCO Annual Meeting     4/20/2015
Opexa Therapeutics (OPXA) Invited To Present Biomarker Data From NMO Patients At The American Academy of Neurology 2015 Annual Meeting     4/20/2015
 Career Tips
Sucampo (SCMP) Looks to Add to "Scientific Core" As Global Reach Grows, Says HR     4/16/2015
8 Things That are Hurting Your Resume     4/16/2015
8 Ways to Increase Your Paycheck     4/16/2015
Flexion (FLXN) CEO Discusses Pipeline and Jobs     4/3/2015
What Employers Think When They See Your LinkedIn Profile     4/2/2015
Five Ways to Build Rapport With Your Interviewer     4/2/2015
Relypsa (RLYP) Hits the Big Leagues: New Hires in Almost Every Department     3/19/2015
Four Common Job Applicant Weaknesses     3/19/2015
Three Resume Secrets Professionals Swear By     3/19/2015
Booming PTC Therapeutics (PTCT) Means Job Openings     3/5/2015
Most Frequent Post-Job Interview Mistake     3/5/2015
Five Employer Concerns Every Job Applicant Must Address     3/5/2015
HR Exec Reveals In-Demand Jobs at MyoKardia     2/19/2015
Pfizer (PFE) Buy Means Jobs: Make Sure Your References Are an Asset     2/19/2015
7 Job Search Sins     2/19/2015
 Other News Sources